Colzyx AB presents Q3 Report – 1 November 2022 – 31 January 2023
“Winter is coming”- well not really here in Lund. As the grey weather persists it is a pleasure to have such an interesting company and
“Winter is coming”- well not really here in Lund. As the grey weather persists it is a pleasure to have such an interesting company and
Colzyx AB (Colzyx) and the European Innovation Council Fund (EIC Fund) have signed the agreement for the first investment of EUR 1m in Colzyx by
Pre‐clinical work is concluded. The work confirms a superior in vivo effect of WOUNDCOM with respect to wound healing promotion, antibacterial effect and biocompatibility.
Collaboration Agreement is signed with global provider of peptide‐synthesis services
Grant agreement is signed between Colzyx and the European Commission.